The Lewiston, Maine, mass shooting was the first test of Biden’s new gun violence prevention office
Published Sun, 16 Feb 2025 16:16:57 GMT
Newfoundland and Labrador’s Union House Arts wins $50K Lacey Prize
Published Sun, 16 Feb 2025 16:16:57 GMT
5 Republicans will take the stage in Miami, while Trump holds a rally nearby. Follow live updates
Published Sun, 16 Feb 2025 16:16:57 GMT
The family of a Palestinian activist jailed for incitement says young woman’s account was hacked
Published Sun, 16 Feb 2025 16:16:57 GMT
General Motors tells AP it is only interested in entering Formula One with Andretti Global
Published Sun, 16 Feb 2025 16:16:57 GMT
Democratic lawmakers want President Biden to protect Palestinians in US from being forced home
Published Sun, 16 Feb 2025 16:16:57 GMT
$600K winning Lucky Day Lotto ticket sold at Jewel-Osco in Woodlawn
Published Sun, 16 Feb 2025 16:16:57 GMT
Coroner: Inmate died from blunt force trauma at Indiana prison
Published Sun, 16 Feb 2025 16:16:57 GMT
City of Evanston offers free parking promotion during holiday season
Published Sun, 16 Feb 2025 16:16:57 GMT
Man arrested for alleged armed robbery of Illinois casino
Published Sun, 16 Feb 2025 16:16:57 GMT
Latest news
- RPM International, Acuity Brands rise; Cal-Maine, Helen of Troy fall, Wednesday, 10/4/2023
- Kenyan opposition lawmakers say the Haiti peacekeeping mission must be approved by parliament
- Tennis player apologizes for hitting a chair umpire with ball in Shanghai Masters qualifying
- Jannik Sinner wins China Open. Iga Swiatek advances to quarterfinals
- Pakistani army says 2 people were killed when a Taliban guard opened fire at a border crossing
- Meet this year’s MacArthur ‘genius grant’ recipients, including a hula master and the poet laureate
- A man charged with voter fraud in Florida blames rivalry between Trump and DeSantis supporters
- Rudy Giuliani: ‘I have never had an alcohol problem’
- Scalise and Jordan launch bids for House speaker after McCarthy ouster
- Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says